TREATMENT OF MULTIPLE SCLEROSIS WITH MASITINIB

摘要

The present invention relates to a tyrosine kinase inhibitor or a mast cell inhibitor, and in particular masitinib or a pharmaceutically acceptable salt thereof, for the treatment of human multiple sclerosis.